Uwe Holtrich
Frankfurt Am Main, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Molecular differences between younger versus older ER-positive and HER2-negative breast cancers.
Journal: NPJ breast cancer
Published: March 26, 2022
Sphingosine-kinase-1 expression is associated with improved overall survival in high-grade serous ovarian cancer.
Journal: Journal of cancer research and clinical oncology
Published: October 21, 2020
Tumor mutational burden and immune infiltration as independent predictors of response to neoadjuvant immune checkpoint inhibition in early TNBC in GeparNuevo.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 24, 2020
Correction: Targeting of PYK2 Synergizes with EGFR Antagonists in Basal-like TNBC and Circumvents HER3-Associated Resistance via the NEDD4-NDRG1 Axis.
Journal: Cancer research
Published: January 17, 2020
Histotype-specific analysis of acid ceramidase expression in ovarian cancer.
Journal: Virchows Archiv : an international journal of pathology
Published: August 27, 2019
A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 18, 2019
Catheter-related Complications of Subcutaneous Implantable Venous Access Devices in Breast Cancer Patients.
Journal: In vivo (Athens, Greece)
Published: May 31, 2018
Claudin-1 is linked to presence of implants and micropapillary pattern in serous borderline epithelial tumours of the ovary.
Journal: Journal of clinical pathology
Published: May 25, 2018
Association Between Genomic Metrics and Immune Infiltration in Triple-Negative Breast Cancer.
Journal: JAMA oncology
Published: July 28, 2017
Claudin-1 expression in cervical cancer.
Journal: Molecular and clinical oncology
Published: March 10, 2017
IMP3 Expression in Borderline Tumors of the Ovary.
Journal: Anticancer research
Published: November 25, 2016
TFF3 Expression as Stratification Marker in Borderline Epithelial Tumors of the Ovary.
Journal: Pathology oncology research : POR
Published: November 01, 2016
Last Updated: 09/26/2026